MEMBRANE-DIFFUSION OF THE LUNGS IN PATIENTS WITH CHRONIC-RENAL-FAILURE

被引:0
|
作者
MOINARD, J [1 ]
GUENARD, H [1 ]
机构
[1] HOP PELLEGRIN, SERV EXPLORAT FONCT RESP, F-33076 BORDEAUX, FRANCE
关键词
CHRONIC RENAL FAILURE; DIFFUSION; HEMODIALYSIS; HYPOXEMIA; TRANSFER FACTOR;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Patients with chronic renal failure (CRF) and haemodialysis treatment usually have a reduced CO transfer factor. The aim of this study was to evaluate the effects of alveolar wall fibrosis and of anaemia on gas diffusion in the lungs. The NO and CO transfer factors of the lung (TLNO and TLCO) were measured, simultaneously, in 15 patients haemodialysed three times a week for 1-10 yrs. Assuming that NO is highly reactive with blood, TLNO is thus directly proportional to the membrane diffusion factor (DmCO). The lung capillary blood volume (Vc) was derived from the set of the two transfer equations. Transfer factors were measured between haemodialysis sessions. All patients but one were anaemic, with haemoglobin concentrations ranging 61-151 g.l-1. All had decreased Vc, and a decreased DmCO was observed in 14 patients. However, after correction for the anaemia, Vc values were normal with the exception of three patients. The percentage decrease in DmCO with respect to normal was correlated with the time elapsed since the first haemodialysis. These results support the idea of a progressive development of haemodialysis-induced chronic lung disease, that may be related to a mechanism of complement activation by a bio-incompatible membrane (Cuprophane). Accordingly, patients with compromised cardiopulmonary functions should be dialysed with a bio-compatible membrane.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 50 条
  • [41] ERYTHROPOIETIN THERAPY IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    PINEVICH, AJ
    PETERSEN, J
    WESTERN JOURNAL OF MEDICINE, 1992, 157 (02): : 154 - 157
  • [42] EFFECTS OF NITRENDIPINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    DALCANTON, A
    ESPOSITO, C
    SABBATINI, M
    ALTOMONTE, M
    ROMANO, G
    VENIERO, P
    UCCELLO, F
    ANDREUCCI, VE
    AMERICAN JOURNAL OF NEPHROLOGY, 1986, 6 : 162 - 164
  • [43] THYROID STATUS IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    BECKETT, GJ
    HENDERSON, CJ
    ELWES, R
    SETH, J
    LAMBIE, AT
    CLINICAL NEPHROLOGY, 1983, 19 (04) : 172 - 178
  • [44] HYPOMETABOLISM IN PATIENTS WITH CHRONIC-RENAL-FAILURE (CRF)
    LIM, VS
    ZAVALA, D
    FLANIGAN, M
    CLINICAL RESEARCH, 1984, 32 (02): : A269 - A269
  • [45] LIPID PROFILE OF PATIENTS OF CHRONIC-RENAL-FAILURE
    AVASTHI, G
    MITTAL, D
    SONI, GL
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1986, 84 : 612 - 616
  • [46] INFLUENZA VACCINATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    NIKOSKELAINEN, J
    VAANANEN, P
    FORSSTROM, J
    KASANEN, A
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1982, 14 (04) : 245 - 251
  • [47] APPLICATION OF HEMODIAFILTRATION IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    Y, JA
    LIU, JW
    WU, Y
    NIE, XJ
    WANG, QP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 417 - 417
  • [48] ERYTHROPOIETIN AND HYPERTENSION OF CHRONIC-RENAL-FAILURE PATIENTS
    SIMON, P
    REVUE DE MEDECINE INTERNE, 1995, 16 (06): : 457 - 461
  • [49] PREDENTIN CHANGES IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    WYSOCKI, GP
    DALEY, TD
    ULAN, RA
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1983, 56 (02): : 167 - 173
  • [50] PHARMACOKINETICS OF RANITIDINE IN PATIENTS WITH CHRONIC-RENAL-FAILURE
    MCFADYEN, ML
    FOLB, PI
    MILLER, R
    KEETON, GR
    MARKS, IN
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (03) : 347 - 351